On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1450 AM Holland, MI

Weather

Current Conditions(Holland,MI 49422)

More Weather »
82° Feels Like: 84°
Wind: W 14 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy 88°

Tonight

Scattered Thunderstorms 65°

Tomorrow

Mostly Sunny 79°

UCB says had positive trial for Vimpat as monotherapy

BRUSSELS (Reuters) - Belgian pharmaceutical company UCB said on Tuesday its new epilepsy treatment Vimpat had produced promising results in a Phase III trial into its use without other drugs.

UCB said it would to submit the data as part of a supplementary new drug application for lacosamide, marketed as Vimpat, to the U.S. Food and Drug Administration. The application is planned in the second half of 2013.

Vimpat is approved as an adjunctive therapy for the treatment of partial-onset seizures in adults with epilepsy, but not as a monotherapy.

(Reporting by Philip Blenkinsop)

Comments